Why This Soaring Canadian Dividend Stock Can Handle Any Market

Cascades (TSX:CAS) stands out as a dividend stock that can’t be stopped, even by economic headwinds.

Key Points
  • If you haven’t lived through a bear market, prioritize dividend stocks tied to steady, everyday demand that can keep improving even when the economy cools.
  • Cascades is surging on a strong quarter and real margin and balance-sheet progress, and it still looks reasonably priced with a ~2.8% yield despite the recent run.

For new investors who have never had the opportunity to invest through a vicious bear market, it can pay dividends to focus on Canadian dividend payers that can find a way to keep on growing, even in down economies. Indeed, right now, we’re in the midst of a bull market, one that might be made even fiercer as the rise of AI looks to drive some kind of productivity gains.

3 colorful arrows racing straight up on a black background.

Source: Getty Images

Cascades: The mid-cap dividend stock that’s gaining ground

Either way, shares of Cascades (TSX: CAS) have really been picking up traction, gaining an outstanding 60% in the past three months. The company is in the steady, but boring and often choppy business of hygiene paper products, much of which incorporates recycled fibres. Whether we’re talking about cardboard boxes, tissues, or other eco-friendly packaging that we really don’t think all too much about on the day-to-day, Cascades is the firm that stands behind such essential products consumed across the continent.

Despite the impressive breakout rally to nearly $17 per share, shares of CAS are still priced like a value stock, now going for 16.8 times trailing price to earnings (P/E), while also yielding a very generous 2.82%.

Of course, pulp price fluctuations will always pave the way for volatility, but the key thing here for investors is that such price moves are likely to be less correlated with the broader TSX Index. For investors seeking mid-cap exposure ($1.71 billion market cap) and one of the least-talked-about economic moats out there, I do think Cascades is worth a closer look, even though the parabolic bounce means that the easy money has already been made.

What a quarter that was!

With a solid second-quarter number in the books that demonstrated fundamental improvements right across the board, I think there’s little reason to book profits, even though I’m sure parabolic surges are enough to make just about any value investor a tad more nervous. With cost reduction efforts finally (literally) paying dividends and the firm continuing to improve the state of its balance sheet through deleveraging, I wouldn’t sleep on the name, especially as the firm looks to continue operating at a high level.

Indeed, tissue products and paper towels are not an exciting industry. But with the recent margin gains, which I believe are here to stay, and the tissue expansion to bring on new capacity to meet healthy demand, I think that a name like Cascades can find a way to fare well, regardless of what the Canadian economy ends up doing next.

What’s most exciting about the Cascades story, at least in my very humble opinion, is not that demand is relatively steady in most environments (cardboard, tissues, and all the sort are a necessity in economic expansions and contractions), but the trajectory of margins, which I believe to be structural.

The bottom line

As the company operates more efficiently while expanding steadily, I see the firm as being able to keep impressing, even when commodity price moves don’t go the firm’s way. All considered, Cascades is on track to hit $600 million of run-rate adjusted EBITDA for the second half of the year. That’s seriously impressive for a firm whose shares were stuck in limbo for so long.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

coins jump into piggy bank
Bank Stocks

Thinking About Bank Stocks? Here’s What to Know in September

After a strong run so far this year, here’s what Canadian investors should know about the big bank stocks in…

Read more »

businessmen shake hands to close a deal
Investing

Carney’s Investment Summit: What Canadian Investors Need to Know

Here’s why Carney’s investment summit earlier this month could benefit high-quality TSX stocks for years to come.

Read more »

a-developer-typing-lines-of-ai-code-while-viewing-multiple-computer-monitors
Dividend Stocks

Thomson Reuters Is a Sneaky AI Play, and Its Stock Popped Earlier This Month

Thomson Reuters is an AI play, building AI into tools legal and tax professionals already use. See why TRI stock…

Read more »

earn passive income by investing in dividend paying stocks
Retirement

The Lazy Canadian’s Path to a Bigger Retirement: 1 Stock to Start With

This Canadian stock’s growing earnings, expanding retirement platform, and steady shareholder returns make it a compelling long-term holding for retirement…

Read more »

A lake in the shape of a solar, wind and energy storage system in the middle of a lush forest as a metaphor for the concept of clean and organic renewable energy.
Dividend Stocks

This Stock Belongs in Every Canadian’s TFSA, and Here’s Why

With a yield of 5.5% and 15 straight years of dividend increases, this TSX stock is a no-brainer buy in…

Read more »

woman looks ahead of her over water
Dividend Stocks

1 Move That Could Ease Your Retirement Worries

Holding the Vanguard FTSE Canadian High Yield ETF (TSX:VDY) in a TFSA can help you pay for your retirement.

Read more »

jar with coins and plant
Dividend Stocks

The Small Dividend Today That Could Grow Significanlty in 20 Years

A small 1.6% yield may not look exciting today, but this Canadian stock’s growing earnings, rising dividend, and long-term investments…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf’s Takeover Bid for Aurora Cannabis: What Investors Need to Know

Curaleaf's takeover bid for Aurora Cannabis offers a premium but brings stock, debt, and deal risks. Here’s what ACB investors…

Read more »